Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Colazal is a prescription aminosalicylate containing balsalazide disodium. It is used for mildly to moderately active ulcerative colitis in adults and children age 5 and older. Capsules contain 750 mg of balsalazide disodium. Treatment duration differs between adults and pediatric patients under current labeling.
read more about colazal ...Balsalazide reaches the colon largely intact, where intestinal bacteria split it into mesalamine and an inert carrier. Mesalamine acts locally on the colonic lining and reduces inflammatory activity. Its exact anti-inflammatory mechanism is not fully defined.
Colazal treats mildly to moderately active ulcerative colitis in patients age 5 and older. Safety and efficacy beyond eight weeks have not been established in patients age 5 to 17. In adults, current labeling states that safety and efficacy beyond 12 weeks have not been established.
Adults take three 750 mg capsules three times daily for up to eight weeks, with some clinical-trial patients treated for up to 12 weeks. Patients age 5 to 17 use either three capsules three times daily or one capsule three times daily for up to eight weeks. Capsules can be swallowed whole or opened onto applesauce.
Serious concerns include kidney impairment, mesalamine-induced acute intolerance syndrome, hypersensitivity reactions, liver failure, severe skin reactions, upper gastrointestinal obstruction, photosensitivity, and kidney stones. Kidney function is checked before treatment and periodically during therapy. Adequate fluid intake reduces the risk of kidney stone formation.
Colazal treats mildly to moderately active ulcerative colitis in patients age 5 and older.
Adults take three 750 mg capsules three times daily for up to eight weeks under current labeling.
Yes. The contents can be sprinkled on applesauce and taken immediately when swallowing whole capsules is difficult.
Yes. Kidney function is checked before treatment and periodically during therapy.
Balsalazide. MedlinePlus. https://www.medlineplus.gov/druginfo/meds/a699052.html. Date Accessed September 23, 2026.
Balsalazide. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/80573-04-2. Date Accessed September 23, 2026.
COLAZAL (balsalazide disodium) Capsules. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22f41e83-b9fb-4c9e-8cc3-f457034191a8. Date Accessed September 23, 2026.
DailyMed - BALSALAZIDE DISODIUM capsule. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f12ffa32-d14b-e9d9-e957-2ef08b64e8b4. Date Accessed September 23, 2026.
New Pediatric Labeling Information Database - Colazal (balsalazide). U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/sda/sdDetailNavigation.cfm?id=14CE032258981B7DE053564DA8C071F2&rownum=618&sd=labelingdatabase. Date Accessed September 23, 2026.